Low platelet count is associated with ductus arteriosus patency in preterm newborns.

[1]  A. Ohlsson,et al.  Ibuprofen for the prevention of patent ductus arteriosus in preterm and/or low birth weight infants. , 2011, The Cochrane database of systematic reviews.

[2]  N. Hills,et al.  Relationship between circulating platelet counts and ductus arteriosus patency after indomethacin treatment. , 2011, The Journal of pediatrics.

[3]  N. Uraş,et al.  Efficacy and safety of oral versus intravenous ibuprofen in very low birth weight preterm infants with patent ductus arteriosus. , 2011, The Journal of pediatrics.

[4]  Sompal Singh,et al.  Platelet indices in diabetes mellitus: indicators of diabetic microvascular complications , 2011, Hematology.

[5]  G. De Luca,et al.  Platelet distribution width and the extent of coronary artery disease: Results from a large prospective study , 2010, Platelets.

[6]  B. Poindexter,et al.  Neonatal Outcomes of Extremely Preterm Infants From the NICHD Neonatal Research Network , 2010, Pediatrics.

[7]  G. Hansmann,et al.  Patent Ductus Arteriosus of the Preterm Infant , 2010, Pediatrics.

[8]  Deepak L. Bhatt,et al.  Mean platelet volume as a predictor of cardiovascular risk: a systematic review and meta‐analysis , 2010, Journal of thrombosis and haemostasis : JTH.

[9]  D. Armangil,et al.  Mean platelet volume in neonatal respiratory distress syndrome , 2009, Pediatrics international : official journal of the Japan Pediatric Society.

[10]  S. Kacem,et al.  Randomized Pilot Study Comparing Oral Ibuprofen With Intravenous Ibuprofen in Very Low Birth Weight Infants With Patent Ductus Arteriosus , 2008, Pediatrics.

[11]  N. Boo,et al.  Predictors of failed closure of patent ductus arteriosus with indomethacin. , 2006, Singapore medical journal.

[12]  N. Usui,et al.  Platelet size deviation width, platelet large cell ratio, and mean platelet volume have sufficient sensitivity and specificity in the diagnosis of immune thrombocytopenia , 2005, British journal of haematology.

[13]  B. Yoder,et al.  The Role of Monocyte-Derived Cells and Inflammation in Baboon Ductus Arteriosus Remodeling , 2005, Pediatric Research.

[14]  G. Lip,et al.  Platelet activation: assessment and quantification. , 2001, European heart journal.

[15]  R. Clyman.  Ibuprofen and patent ductus arteriosus. , 2000, The New England journal of medicine.

[16]  P. Bath,et al.  Platelet size: measurement, physiology and vascular disease. , 1996, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

[17]  Wan Ariffin Bin Abdullah.  Singapore Med J , 1993 .

[18]  M. Silver,et al.  The morphology of the human newborn ductus arteriosus: a reappraisal of its structure and closure with special reference to prostaglandin E1 therapy. , 1981, Human pathology.

[19]  S. Karpatkin.  Heterogeneity of human platelets. II. Functional evidence suggestive of young and old platelets. , 1969, The Journal of clinical investigation.

[20]  S. Karpatkin.  Heterogeneity of human platelets. I. Metabolic and kinetic evidence suggestive of young and old platelets. , 1969, The Journal of clinical investigation.

[21]  G. Kitas,et al.  Mean platelet volume: a link between thrombosis and inflammation? , 2011, Current pharmaceutical design.

[22]  A. Walch,et al.  Platelets contribute to postnatal occlusion of the ductus arteriosus , 2010, Nature Medicine.

[23]  E. Gounari,et al.  Platelet distribution width: a simple, practical and specific marker of activation of coagulation. , 2010, Hippokratia.

[24]  S. Chemtob,et al.  Vessel remodeling in the newborn: platelets fill the gap , 2010, Nature Medicine.

[25]  W. Pittard,et al.  Mean Platelet Volume and Platelet Distribution Width in the Neonate , 1987, The American journal of pediatric hematology/oncology.